Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1992 1
1993 2
1994 3
1995 3
1996 1
1997 2
1998 1
2002 1
2004 1
2008 1
2009 1
2011 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment.
Fessel WJ, Anderson B, Follansbee SE, Winters MA, Lewis ST, Weinheimer SP, Petropoulos CJ, Shafer RW. Fessel WJ, et al. Among authors: weinheimer sp. Antiviral Res. 2011 Dec;92(3):484-7. doi: 10.1016/j.antiviral.2011.09.010. Epub 2011 Oct 4. Antiviral Res. 2011. PMID: 22001594 Free PMC article.
Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults.
Jacobson JM, Kuritzkes DR, Godofsky E, DeJesus E, Larson JA, Weinheimer SP, Lewis ST. Jacobson JM, et al. Among authors: weinheimer sp. Antimicrob Agents Chemother. 2009 Feb;53(2):450-7. doi: 10.1128/AAC.00942-08. Epub 2008 Nov 17. Antimicrob Agents Chemother. 2009. PMID: 19015347 Free PMC article. Clinical Trial.
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page